BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or KLOW is a multi peptide blend composed of KPV, BPC 157, TB 500, and GHK Cueach studied for its role in inflammation response, tissue repair, and overall recovery signaling. KPV is researched for its interaction with KLOW TB 500 10mg BPC 157 10mg KPV 10mg GHK Cu 50mg BPC 157 + TB 500 + KPV + GHK Cu (KLOW) 10 10 10 50mg Olympic Peptide